Alera Investment Advisors’s Streamline Health Solutions STRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,667
Closed -$42.5K 178
2023
Q4
$42.5K Hold
6,667
0.01% 166
2023
Q3
$96.8K Hold
6,667
0.02% 155
2023
Q2
$127K Hold
6,667
0.03% 164
2023
Q1
$180K Sell
6,667
-250
-4% -$7.09K 0.04% 161
2022
Q4
$164K Hold
6,917
0.04% 166
2022
Q3
$123K Hold
6,917
0.03% 162
2022
Q2
$132K Hold
6,917
0.04% 174
2022
Q1
$166K Hold
6,917
0.04% 178
2021
Q4
$155K Hold
6,917
0.04% 99
2021
Q3
$182K Hold
6,917
0.05% 93
2021
Q2
$184K Hold
6,917
0.06% 93
2021
Q1
$213K Hold
6,917
0.07% 84
2020
Q4
$162K Hold
6,917
0.06% 85
2020
Q3
$162K Hold
6,917
0.06% 83
2020
Q2
$138K Hold
6,917
0.07% 75
2020
Q1
$88K Hold
6,917
0.05% 66
2019
Q4
$144K Hold
6,917
0.07% 62
2019
Q3
$113K Buy
+6,917
New +$143K 0.06% 75
2019
Q2
Sell
-6,917
Closed -$109K 872
2019
Q1
$109K Buy
6,917
+6,600
+2,082% +$110K 0.05% 99
2018
Q4
$4K Buy
+317
New +$4.29K ﹤0.01% 654

Other funds holding STRM

Alera Investment Advisors's STRM Position: Q1 2024 in Review

Alera Investment Advisors sold out of Streamline Health Solutions (STRM) in Q1 2024, closing a stake of 6,667 shares — an estimated $42.5K sold.

Alera Investment Advisors first reported a position in STRM in Q4 2018 and held it in 20 quarters. The position peaked at $213K in Q1 2021. 29 funds tracked by Wall St. Rank hold STRM as of Q1 2024.

  • Alera Investment Advisors reported no remaining Streamline Health Solutions position as of Q1 2024 after selling out during the quarter.
  • Alera Investment Advisors sold 6,667 Streamline Health Solutions shares in Q1 2024, an estimated $42.5K.
  • Alera Investment Advisors first reported a position in Streamline Health Solutions in Q4 2018 and held it in 20 quarters.
  • Alera Investment Advisors's Streamline Health Solutions position peaked at $213K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Streamline Health Solutions as of Q1 2024.

Based on Alera Investment Advisors's 13F filing for Q1 2024, filed 10 May 2024.